Amgen (AMGN) Tops Q1 EPS by 38c; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amgen (AMGN) Price Target Raised to $195 at Jefferies
April 22, 2015 11:41 AM EDTIn a note earlier, Jefferies analyst Eun K. Yang reiterated a Buy rating and boosted his price target on Amgen (NASDAQ: AMGN) to $195.00 (from $182.00) following Q1 results.
Yang commented, "Reported ~18% higher EPS (vs. cons) on ~3% higher product sales & lower OpEx; upped FY15 EPS guidance... More
Amgen (AMGN) Price Target Lifted to $187 at Leerink Partners
April 22, 2015 7:49 AM EDTLeerink Partners analyst Howard Liang reiterated an Outperform rating and boosted estimates and his price target on Amgen (NASDAQ: AMGN) to $187.00 (from $177.00) following strong results.
Liang commented, "AMGN reported a strong first quarter last night, with a broad range of products contributing to a ~$117M sales beat vs. consensus and approximately twice this number in lower-than-expected operating expenses, leading to... More
Amgen (AMGN) Modestly Higher Into Q1 Results
April 21, 2015 2:09 PM EDTAmgen (NASDAQ: AMGN) is up 1% into earnings after the close of trading today. Analysts on average are looking for EPS of $2.10 on revenues of $4.91 billion, representing year-over-year growth of 12% and 9%, respectively. On average over the past four quarters, the company has beaten the EPS consensus by 6%. The... More
